Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.

van den Broek AJ, van 't Veer LJ, Hooning MJ, Cornelissen S, Broeks A, Rutgers EJ, Smit VT, Cornelisse CJ, van Beek M, Janssen-Heijnen ML, Seynaeve C, Westenend PJ, Jobsen JJ, Siesling S, Tollenaar RA, van Leeuwen FE, Schmidt MK.

J Clin Oncol. 2016 Feb 10;34(5):409-18. doi: 10.1200/JCO.2015.62.3942. Epub 2015 Dec 23.

PMID:
26700119
2.

Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.

Hoekstra AS, de Graaff MA, Briaire-de Bruijn IH, Ras C, Seifar RM, van Minderhout I, Cornelisse CJ, Hogendoorn PC, Breuning MH, Suijker J, Korpershoek E, Kunst HP, Frizzell N, Devilee P, Bayley JP, Bovée JV.

Oncotarget. 2015 Nov 17;6(36):38777-88. doi: 10.18632/oncotarget.6091.

3.

Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.

Hensen EF, Siemers MD, Jansen JC, Corssmit EP, Romijn JA, Tops CM, van der Mey AG, Devilee P, Cornelisse CJ, Bayley JP, Vriends AH.

Clin Endocrinol (Oxf). 2011 Nov;75(5):650-5. doi: 10.1111/j.1365-2265.2011.04097.x.

PMID:
21561462
4.

Paired distribution of molecular subtypes in bilateral breast carcinomas.

Russnes HG, Kuligina ESh, Suspitsin EN, Voskresenskiy DA, Jordanova ES, Cornelisse CJ, Borresen-Dale AL, Imyanitov EN.

Cancer Genet. 2011 Feb;204(2):96-102. doi: 10.1016/j.cancergencyto.2010.09.012.

PMID:
21504707
5.

High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.

Hensen EF, van Duinen N, Jansen JC, Corssmit EP, Tops CM, Romijn JA, Vriends AH, van der Mey AG, Cornelisse CJ, Devilee P, Bayley JP.

Clin Genet. 2012 Mar;81(3):284-8. doi: 10.1111/j.1399-0004.2011.01653.x. Epub 2011 Mar 15.

PMID:
21348866
6.

Sdhd and SDHD/H19 knockout mice do not develop paraganglioma or pheochromocytoma.

Bayley JP, van Minderhout I, Hogendoorn PC, Cornelisse CJ, van der Wal A, Prins FA, Teppema L, Dahan A, Devilee P, Taschner PE.

PLoS One. 2009 Nov 24;4(11):e7987. doi: 10.1371/journal.pone.0007987.

7.

The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family.

Hensen EF, Jansen JC, Siemers MD, Oosterwijk JC, Vriends AH, Corssmit EP, Bayley JP, van der Mey AG, Cornelisse CJ, Devilee P.

Eur J Hum Genet. 2010 Jan;18(1):62-6. doi: 10.1038/ejhg.2009.112.

8.

Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis.

Hensen EF, Goeman JJ, Oosting J, Van der Mey AG, Hogendoorn PC, Cremers CW, Devilee P, Cornelisse CJ.

BMC Med Genomics. 2009 May 11;2:25. doi: 10.1186/1755-8794-2-25.

9.

Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.

Corver WE, Middeldorp A, ter Haar NT, Jordanova ES, van Puijenbroek M, van Eijk R, Cornelisse CJ, Fleuren GJ, Morreau H, Oosting J, van Wezel T.

Cancer Res. 2008 Dec 15;68(24):10333-40. doi: 10.1158/0008-5472.CAN-08-2665.

10.

Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs.

Vreeswijk MP, Kraan JN, van der Klift HM, Vink GR, Cornelisse CJ, Wijnen JT, Bakker E, van Asperen CJ, Devilee P.

Hum Mutat. 2009 Jan;30(1):107-14. doi: 10.1002/humu.20811.

PMID:
18693280
11.

Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus.

Oldenburg RA, Kroeze-Jansema KH, Houwing-Duistermaat JJ, Bayley JP, Dambrot C, van Asperen CJ, van den Ouweland AM, Bakker B, van Beers EH, Nederlof PM, Vasen H, Hoogerbrugge N, Cornelisse CJ, Meijers-Heijboer H, Devilee P.

Genes Chromosomes Cancer. 2008 Nov;47(11):947-56. doi: 10.1002/gcc.20597.

PMID:
18663745
12.

A family history of breast cancer will not predict female early onset breast cancer in a population-based setting.

de Bock GH, Jacobi CE, Seynaeve C, Krol-Warmerdam EM, Blom J, van Asperen CJ, Cornelisse CJ, Klijn JG, Devilee P, Tollenaar RA, Brekelmans CT, van Houwelingen JC.

BMC Cancer. 2008 Jul 23;8:203. doi: 10.1186/1471-2407-8-203.

13.

Gene-expression of metastasized versus non-metastasized primary head and neck squamous cell carcinomas: a pathway-based analysis.

Hensen EF, De Herdt MJ, Goeman JJ, Oosting J, Smit VT, Cornelisse CJ, Baatenburg de Jong RJ.

BMC Cancer. 2008 Jun 10;8:168. doi: 10.1186/1471-2407-8-168.

14.

ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.

Cleton-Jansen AM, van Eijk R, Lombaerts M, Schmidt MK, Van't Veer LJ, Philippo K, Zimmerman RM, Peterse JL, Smit VT, van Wezel T, Cornelisse CJ.

BMC Cancer. 2008 Apr 16;8:105. doi: 10.1186/1471-2407-8-105.

15.

Frequent mutations in the 3'-untranslated region of IFNGR1 lack functional impairment in microsatellite-unstable colorectal tumours.

Dierssen JW, van Puijenbroek M, Dezentjé DA, Fleuren GJ, Cornelisse CJ, van Wezel T, Offringa R, Morreau H.

Eur J Hum Genet. 2008 Oct;16(10):1235-9. doi: 10.1038/ejhg.2008.81. Epub 2008 Apr 16.

16.

Genetic susceptibility for breast cancer: how many more genes to be found?

Oldenburg RA, Meijers-Heijboer H, Cornelisse CJ, Devilee P.

Crit Rev Oncol Hematol. 2007 Aug;63(2):125-49. Epub 2007 May 10. Review.

PMID:
17498966
17.

Searching for susceptibility alleles: emphasis on bilateral breast cancer.

Imyanitov EN, Cornelisse CJ, Devilee P.

Int J Cancer. 2007 Aug 15;121(4):921-3. Review. No abstract available.

18.

Changes in selected physiological and laboratory measurements in elite horses competing in a 160 km endurance ride.

Schott HC 2nd, Marlin DJ, Geor RJ, Holbrook TC, Deaton CM, Vincent T, Dacre K, Schroter RC, Jose-Cunilleras E, Cornelisse CJ.

Equine Vet J Suppl. 2006 Aug;(36):37-42.

PMID:
17402389
19.

HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.

Dierssen JW, de Miranda NF, Ferrone S, van Puijenbroek M, Cornelisse CJ, Fleuren GJ, van Wezel T, Morreau H.

BMC Cancer. 2007 Feb 22;7:33.

20.

Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.

Schmidt MK, Tollenaar RA, de Kemp SR, Broeks A, Cornelisse CJ, Smit VT, Peterse JL, van Leeuwen FE, Van't Veer LJ.

J Clin Oncol. 2007 Jan 1;25(1):64-9. Epub 2006 Nov 28.

PMID:
17132695
21.

Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias.

Suspitsin EN, Sokolenko AP, Togo AV, Lazareva YR, Turkevich EA, Matsko DE, Henrich KO, Borresen-Dale AL, Schwab M, Cornelisse CJ, Imyanitov EN.

Int J Cancer. 2007 Jan 15;120(2):297-302.

22.

High-resolution analysis of HLA class I alterations in colorectal cancer.

Dierssen JW, de Miranda NF, Mulder A, van Puijenbroek M, Verduyn W, Claas FH, van de Velde CJ, Jan Fleuren G, Cornelisse CJ, Corver WE, Morreau H.

BMC Cancer. 2006 Oct 2;6:233.

23.

Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.

de Bock GH, Mourits MJ, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG.

Int J Gynecol Cancer. 2006;16 Suppl 2:552-5.

PMID:
17010071
24.

Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism.

Douwes Dekker PB, Kuipers-Dijkshoorn NJ, Baelde HJ, van der Mey AG, Hogendoorn PC, Cornelisse CJ.

Hum Pathol. 2007 Jan;38(1):79-85. Epub 2006 Aug 1.

PMID:
16949906
25.

A genome wide linkage search for breast cancer susceptibility genes.

Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G; kConFab Investigators, Szabo C, Southey M, Renard H, Odefrey F, Lynch H, Stoppa-Lyonnet D, Couch F, Hopper JL, Giles GG, McCredie MR, Buys S, Andrulis I, Senie R; BCFS, BRCAX Collaborators Group, Goldgar DE, Oldenburg R, Kroeze-Jansema K, Kraan J, Meijers-Heijboer H, Klijn JG, van Asperen C, van Leeuwen I, Vasen HF, Cornelisse CJ, Devilee P, Baskcomb L, Seal S, Barfoot R, Mangion J, Hall A, Edkins S, Rapley E, Wooster R, Chang-Claude J, Eccles D, Evans DG, Futreal P, Nathanson KL, Weber BL; Breast Cancer Susceptibility Collaboration (UK), Rahman N, Stratton MR.

Genes Chromosomes Cancer. 2006 Jul;45(7):646-55.

26.

Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.

Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H, van Asperen CJ, Hoogerbrugge N, van Leeuwen I, Vasen HF, Cleton-Jansen AM, Kraan J, Houwing-Duistermaat JJ, Morreau H, Cornelisse CJ, Devilee P.

Clin Cancer Res. 2006 Mar 15;12(6):1693-700.

27.

Thermographic study of in vivo modulation of vascular responses to phenylephrine and endothelin-1 by dexamethasone in the horse.

Cornelisse CJ, Robinson NE, Berney CA, Eberhart S, Hauptman JE, Derksen FJ.

Equine Vet J. 2006 Mar;38(2):119-26.

PMID:
16536380
28.

E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.

Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de Water B, Cornelisse CJ, Cleton-Jansen AM.

Br J Cancer. 2006 Mar 13;94(5):661-71.

29.

FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.

Kumar R, Neilsen PM, Crawford J, McKirdy R, Lee J, Powell JA, Saif Z, Martin JM, Lombaerts M, Cornelisse CJ, Cleton-Jansen AM, Callen DF.

Cancer Res. 2005 Dec 15;65(24):11304-13.

30.

Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.

van Wezel T, Lombaerts M, van Roon EH, Philippo K, Baelde HJ, Szuhai K, Cornelisse CJ, Cleton-Jansen AM.

Breast Cancer Res. 2005;7(6):R998-1004. Epub 2005 Oct 18.

31.

Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors.

Sieben NL, Oosting J, Flanagan AM, Prat J, Roemen GM, Kolkman-Uljee SM, van Eijk R, Cornelisse CJ, Fleuren GJ, van Engeland M.

J Clin Oncol. 2005 Oct 10;23(29):7257-64. Epub 2005 Aug 8.

PMID:
16087957
32.

Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma.

Majdak EJ, Debniak J, Milczek T, Cornelisse CJ, Devilee P, Emerich J, Jassem J, De Bock GH.

Cancer. 2005 Sep 1;104(5):1004-12.

33.

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.

Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, Bishop T, Benitez J, Rivas C, Bignon YJ, Chang-Claude J, Hamann U, Cornelisse CJ, Devilee P, Beckmann MW, Nestle-Krämling C, Daly PA, Haites N, Varley J, Lalloo F, Evans G, Maugard C, Meijers-Heijboer H, Klijn JG, Olah E, Gusterson BA, Pilotti S, Radice P, Scherneck S, Sobol H, Jacquemier J, Wagner T, Peto J, Stratton MR, McGuffog L, Easton DF; Breast Cancer Linkage Consortium.

Clin Cancer Res. 2005 Jul 15;11(14):5175-80.

34.

High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues.

Corver WE, Ter Haar NT, Dreef EJ, Miranda NF, Prins FA, Jordanova ES, Cornelisse CJ, Fleuren GJ.

J Pathol. 2005 Jun;206(2):233-41.

PMID:
15822070
35.

Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas.

van Houtum WH, Corssmit EP, Douwes Dekker PB, Jansen JC, van der Mey AG, Bröcker-Vriends AH, Taschner PE, Losekoot M, Frölich M, Stokkel MP, Cornelisse CJ, Romijn JA.

Eur J Endocrinol. 2005 Jan;152(1):87-94.

PMID:
15762191
36.

Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.

van Beers EH, van Welsem T, Wessels LF, Li Y, Oldenburg RA, Devilee P, Cornelisse CJ, Verhoef S, Hogervorst FB, van't Veer LJ, Nederlof PM.

Cancer Res. 2005 Feb 1;65(3):822-7.

37.

Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary report.

Majdak EJ, De Bock GH, Brozek I, Perkowska M, Ochman K, Debniak J, Milczek T, Cornelisse CJ, Jassem J, Emerich J, Limon J, Devilee P.

Eur J Cancer. 2005 Jan;41(1):143-50.

PMID:
15617999
38.

Carotid body tumors in humans caused by a mutation in the gene for succinate dehydrogenase D (SDHD).

Dahan A, Taschner PE, Jansen JC, van der Mey A, Teppema LJ, Cornelisse CJ.

Adv Exp Med Biol. 2004;551:71-6. No abstract available.

PMID:
15602946
39.

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant.

de Bock GH, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG.

J Med Genet. 2004 Oct;41(10):731-5.

40.

Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.

Cleton-Jansen AM, Buerger H, Haar Nt, Philippo K, van de Vijver MJ, Boecker W, Smit VT, Cornelisse CJ.

Genes Chromosomes Cancer. 2004 Oct;41(2):109-16.

PMID:
15287023
41.

Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction.

Cornelisse CJ, Robinson NE, Berney CE, Kobe CA, Boruta DT, Derksen FJ.

Equine Vet J. 2004 Jul;36(5):426-30. Erratum in: Equine Vet J. 2005 Jan;37(1):36.

PMID:
15253084
42.

Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors.

Lombaerts M, Middeldorp JW, van der Weide E, Philippo K, van Wezel T, Smit VT, Cornelisse CJ, Cleton-Jansen AM.

Biochem Biophys Res Commun. 2004 Jun 25;319(2):697-704.

PMID:
15178462
44.

Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families.

Hensen EF, Jordanova ES, van Minderhout IJ, Hogendoorn PC, Taschner PE, van der Mey AG, Devilee P, Cornelisse CJ.

Oncogene. 2004 May 20;23(23):4076-83.

PMID:
15064708
45.

Extending the p16-Leiden tumour spectrum by respiratory tract tumours.

Oldenburg RA, de Vos tot Nederveen Cappel WH, van Puijenbroek M, van den Ouweland A, Bakker E, Griffioen G, Devilee P, Cornelisse CJ, Meijers-Heijboer H, Vasen HF, Morreau H.

J Med Genet. 2004 Mar;41(3):e31. No abstract available.

46.

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

Oldenburg RA, Kroeze-Jansema K, Kraan J, Morreau H, Klijn JG, Hoogerbrugge N, Ligtenberg MJ, van Asperen CJ, Vasen HF, Meijers C, Meijers-Heijboer H, de Bock TH, Cornelisse CJ, Devilee P.

Cancer Res. 2003 Dec 1;63(23):8153-7.

47.

SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology.

Douwes Dekker PB, Hogendoorn PC, Kuipers-Dijkshoorn N, Prins FA, van Duinen SG, Taschner PE, van der Mey AG, Cornelisse CJ.

J Pathol. 2003 Nov;201(3):480-6.

PMID:
14595761
48.

Possible consequences of applying guidelines to healthy women with a family history of breast cancer.

van Asperen CJ, Tollenaar RA, Krol-Warmerdam EM, Blom J, Hoogendoorn WE, Seynaeve CM, Brekelmans CT, Devilee P, Cornelisse CJ, Klijn JG, de Bock GH.

Eur J Hum Genet. 2003 Aug;11(8):633-6.

49.

G2M arrest, blocked apoptosis, and low growth fraction may explain indolent behavior of head and neck paragangliomas.

Dekker PB, Kuipers-Dijkshoorn N, Hogendoorn PC, van der Mey AG, Cornelisse CJ.

Hum Pathol. 2003 Jul;34(7):690-8.

PMID:
12874765
50.

Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

de Bock GH, Tollenaar RA, Papelard H, Vliet Vlieland TP, Devilee P, Cornelisse CJ, Vandenbroucke JP.

J Natl Cancer Inst. 2003 Jul 2;95(13):1011-2; author reply 1012-3. No abstract available.

PMID:
12837842

Supplemental Content

Loading ...
Support Center